1. Genetic and prenatal developmental evaluation of anthraquinone.
- Author
-
Qu, Jingjing, Zhang, Yinjing, Liu, Chunxia, Xie, Qianqian, Ou, Tong, Fan, Bolin, and Song, Yan
- Subjects
- *
FETUS , *ERYTHROCYTES , *GENETIC toxicology , *ANTHRAQUINONES , *CHO cell , *AMES test , *CHROMOSOME abnormalities , *SALMONELLA typhimurium - Abstract
Anthraquinone is a recently identified contaminant present in teas globally, and its potential teratogenic and genotoxic impacts have yet to be fully comprehended. Hence, this study's objective was to determine anthraquinone's genotoxicity using various studies such as the Ames test, Mammalian erythrocyte micronucleus test, and in-vitro mammalian chromosome aberration study. Additionally, the study assessed its effects on maternal gestational toxicity and the fetus's teratogenicity through prenatal developmental toxicity research in rats. Results indicated that anthraquinone did not manifest mutagenic effects on Salmonella typhimurium histidine-deficient, did not cause chromosomal aberrations in Chinese hamster ovary cell subclone CHO-K1, and did not exhibit a genotoxic effect on mouse bone marrow erythrocytes. However, in the prenatal developmental toxicity study, administering anthraquinone orally to pregnant rats from day 5 to day 19 of gestation resulted in decreased body weight and food consumption of pregnant rats, along with a higher number of visceral malformations in the fetuses in the highest dose group (217.6 mg/kg BW). Additionally, two pregnant rats died in this group. The study has established the no observed adverse effect level (NOAEL) as 21.76 mg/kg BW, while the lowest observed adverse effect level (LOAEL) was 217.6 mg/kg BW. [Display omitted] • This paper discusses the genotoxicity and teratotoxicity of anthraquinone. • Anthraquinone is not genotoxic. • The NOAEL for anthraquinone teratology was 21.76 mg/kg, the LOAEL was 217.6 mg/kg. • Data on genotoxicity and prenatal developmental toxicity of anthraquinone were added. • Provides a basis for chronic toxicity design and risk assessment of anthraquinones. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF